Posted on 2/1/21
EyeGate Pharmaceuticals Announces Management Transition
WALTHAM, Mass., Feb. 01, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), a clinical-stage company developing products for treating inflammatory and immune diseases with a . . .
Posted on 2/1/21
Gray To Acquire Quincy Media For $925 Million
Gray Television, Inc. (NYSE: GTN) announced today that it has entered into an agreement to acquire Quincy Media, Inc. for $925 million in cash. Upon closing . . .
Posted on 2/1/21
2021’s Best & Worst States for Singles – WalletHub Study
With Valentine’s Day around the corner and the COVID-19 pandemic leading to a surge in virtual dating, the personal-finance website WalletHub today released its report on . . .
Posted on 2/1/21
Trevi Therapeutics Appoints William Forbes, Pharm.D. as Chief Development Officer
NEW HAVEN, Conn., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio . . .
Posted on 2/1/21
Sensei Biotherapeutics Launch of IPO
BOSTON & ROCKVILLE, Md.--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced that . . .
Posted on 2/1/21
Which Is the Best COVID Vaccine Stock: Pfizer, BioNTech, Moderna, Johnson & Johnson, or Novavax?
Which COVID-19 vaccine is the best? The correct answer is that it depends on which factor is most important to you.Comirnaty (BNT162b2), the vaccine developed by . . .
Posted on 2/1/21
Is Moderna a Long-Term Buy?
Investors flocked to Moderna(NASDAQ:MRNA) last year with hopes its coronavirus vaccine program would bear fruit. Since, the company has become one of the first to commercialize . . .
Posted on 2/1/21
Why Raytheon Technologies Stock Is Set to Soar
If the stock market was a beauty contest, very few investors would be voting for stocks in the commercial aerospace sector right now. However, to paraphrase . . .
Posted on 2/1/21
Yield10 Bioscience Prices of $12.7 Million Public Offering
WOBURN, Mass., Jan. 31, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the pricing of its underwritten public offering . . .
Posted on 1/30/21
CA Healthcare Acquisition Corp. Closes $115M IPO
BOSTON--(BUSINESS WIRE)--CA Healthcare Acquisition Corp. announced today the completion of its initial public offering of 11,500,000 units, including 1,500,000 units issued pursuant to the full exercise by . . .
Posted on 1/30/21
Sensei Biotherapeutics Appoints Deneen Vojta, M.D. to its Board of Directors
Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company focused on the discovery and development of next
Posted on 1/30/21
Yield10 Bioscience Proposes Public Offering of Common Stock
WOBURN, Mass., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it has commenced an underwritten public offering . . .
Posted on 1/30/21
Bioasis Announces $200,000 Non-Brokered Private Placement
GUILFORD, Conn., Jan. 29, 2021 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for . . .
Posted on 1/30/21
Peak Physical Therapy & Sports Performance Staff Received First Dose of COVID-19 Vaccines on January 26th
Director of Operations Shannon Delaney and Owner Eric Edelman after receiving their vaccinesPeak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs . . .
Posted on 1/30/21
Linden Ponds Residents Find it Easy to Stay Engaged and Fit
Amenities and activities make worry-free living a reality Daily exercise is a priority for resident Janet Shipman, who walks five miles a day, indoors and out. . . .
Posted on 1/30/21
Revitalized and Re-engaged at Brooksby Village
Open amenities bring fresh energy after year of uncertainty As amenities at Brooksby Village began to strategically reopen, Carol Bortman was delighted to return to the . . .
Posted on 1/29/21
Janet Forero Elected to American Board of Trial Advocates
Janet Forero, partner at Goodell DeVries, has been inducted into the American Board of Trial Advocates (ABOTA). Janet was officially voted into ABOTA membership at the group's . . .
Posted on 1/29/21
New England industrial Portfolio Acquisition Financed for $9.1M
JLL Capital Markets arranged the loan for Boston-based Rhino Capital AdvisorsJLL Capital Markets announced today that it has arranged $9.1 million in acquisition financing for a . . .
Posted on 1/29/21
Fairmount Partners Advises IntelliSyn and AviSyn in Sale to X-Chem
X-Chem, Inc. (X-Chem), the industry-leading provider of DNA-Encoded Library (DEL)-based discovery services
Posted on 1/29/21
Herrick Lutts Realty Partners to Re-brand as Independent Agency
Herrick Lutts location in Beverly, MA Well-known real estate agency Herrick Lutts Realty Partners, an established commercial and residential real estate firm which has served the . . .
Posted on 1/29/21
Partners Insurance Group Promotes Bernard McDonald to VP, Sales
Partners Insurance Group, LLC, one of the region’s leading independent insurance agencies with eight locations
Posted on 1/29/21
Aware Recovery Care Announces Growth Investment from Health Enterprise Partners
Aware Recovery Care, a pioneer in the in-home addiction treatment space, today announced that it has raised a significant growth investment to support rapid expansion and . . .
Posted on 1/29/21
Charter Announces Fourth Quarter and Full Year 2020 Results
Charter Communications, Inc. today reported financial and operating results for the three and twelve months ended December 31, 2020.Key highlights: As of December 31, 2020, Charter served . . .
Posted on 1/29/21
Synchrony Reports Fourth Quarter Net Earnings of $738 Million
Synchrony Financial (NYSE: SYF) today announced fourth quarter 2020 earnings results amid the continuing Coronavirus (COVID-19) pandemic. Synchrony reported fourth quarter 2020 net earnings of $738 . . .
Posted on 1/29/21
Exacis Biotherapeutics Appoints Dirk Huebner as Chief Medical Officer
Exacis Biotherapeutics, Inc., a development-stage immuno-oncology company working to harness the immune system to cure cancer, today announced the addition of Dirk Huebner, MD, as its . . .
Boston
